PLX logo

Protalix BioTherapeutics, Inc. (PLX)

Profile

Full Name

Protalix BioTherapeutics, Inc.

Ticker

NYSEAmerican: PLX

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 15, 1998

Indexes

Not included

Website

https://www.protalix.com

Employees

213

Key Details

Price

$2.14(0.47%)

Market Cap

$170.63M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$53.40M(-18.47% YoY)

Annual EPS

$0.04(-57.79% YoY)

PE Ratio

28.92

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.14
    PLX price is $2.14

    30-Day Relative Volume

    0.49
    PLX 30-day relative volume is 0.49

    Price Performance

    Price Most Recent Change

    +0.47%
    PLX price was up +0.47% on Nov 12, 2025

    Price YTD Change

    +13.83%
    PLX price is up +13.83% since January 1st

    Price 1-Year Change

    +62.12%
    PLX price is up +62.12% year-on-year

    Price 3-Year Change

    +103.81%
    PLX price is up +103.81% over the past 3 years

    Price Range

    Price All-Time High

    $912.50
    PLX price is currently -99.77% below its historical high of $912.50

    Price 3-Year Low

    $0.82
    PLX price is currently +160.98% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $170.63M
    PLX market cap is $170.63 million

    Market Cap 3-Year Change

    +220.73%
    PLX market cap is up +220.73% over the past 3 years

    Market Cap All-Time High

    $3.00B
    PLX market cap is currently -94.32% below its historical high of $3.00 billion

    Market Cap Sector Percentile

    47.41%
    PLX market cap is higher than 47.41% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +8.28%
    PLX shares outstanding is up +8.28% year-on-year

    Shares Outstanding 3-Year Change

    +57.37%
    PLX shares outstanding is up +57.37% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.76
    PLX beta is 0.76

    200-day SMA

    $2.04
    PLX price is currently +4.85% above its 200-day simple moving average

    50-day SMA

    $2.16
    PLX price is currently -0.74% below its 50-day simple moving average

    14-Day RSI

    45.14
    PLX 14-day relative strength index is 45.14

    Volume

    0.49
    PLX 30-day relative volume is 0.49

    ATR

    $0.15
    PLX average true range is $0.15

    10-day Historical Volatility

    52.55%
    PLX 10-day historical volatility is 52.55%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $53.40M
    PLX annual revenue is $53.40 million

    Revenue Analysts Estimate

    $60.55M
    PLX annual revenue is currently -11.82% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -18.47%
    PLX annual revenue is down -18.47% year-on-year

    Revenue Sector Percentile

    61.93%
    PLX annual revenue is higher than 61.93% of companies in Healthcare sector

    EPS

    EPS

    $0.04
    PLX annual earnings per share is $0.04

    EPS Analysts Estimate

    $0.13
    PLX annual earnings per share is currently -71.85% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -57.79%
    PLX annual earnings per share is down -57.79% year-on-year

    EPS Sector Percentile

    81.78%
    PLX annual earnings per share is higher than 81.78% of companies in Healthcare sector

    Profit

    Gross Profit

    $29.08M
    PLX annual gross profit is $29.08 million

    Gross Margin

    54.46%
    PLX annual gross profit margin is 54.46%

    Operating Profit

    $3.92M
    PLX annual operating income is $3.92 million

    Operating Margin

    7.34%
    PLX annual operating profit margin is 7.34%

    Net Income

    $2.93M
    PLX annual net profit is $2.93 million

    Net Margin

    5.49%
    PLX annual net profit margin is 5.49%

    Expenses

    Total Expenses

    $49.48M
    PLX annual total expenses is $49.48 million

    Operating Expenses

    $25.16M
    PLX annual total operating expenses is $25.16 million

    Cost Of Goods Sold

    $24.32M
    PLX annual cost of goods sold is $24.32 million

    Selling, General & Administrative Expenses

    $12.19M
    PLX annual SG&A is $12.19 million

    Depreciation & Amortization

    $1.30M
    PLX annual D&A is $1.30 million

    Interest Expense

    $0.00
    PLX annual interest expense is $0.00

    Income Tax

    $1.22M
    PLX annual income tax is $1.22 million

    EBIT & EBITDA

    EBIT

    $5.22M
    PLX annual earnings before interest & taxes is $5.22 million

    EBITDA

    $6.52M
    PLX annual EBITDA is $6.52 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $73.42M
    PLX annual total assets is $73.42 million

    Non Current Assets

    $13.34M
    PLX annual long term assets is $13.34 million

    Current Assets

    $60.08M
    PLX annual total current assets is $60.08 million

    Cash and Cash Equivalents

    $19.76M
    PLX annual cash & cash equivalents is $19.76 million

    Accounts Receivable

    $2.91M
    PLX annual accounts receivable is $2.91 million

    Inventory

    $21.24M
    PLX annual inventory is $21.24 million

    Liabilities

    Total Liabilities

    $30.21M
    PLX annual total liabilities is $30.21 million

    Long Term Liabilities

    $4.58M
    PLX annual total long term liabilities is $4.58 million

    Current Liabilities

    $25.62M
    PLX annual current liabilities is $25.62 million

    Accounts Payable

    $4.53M
    PLX annual accounts payable is $4.53 million

    Debt

    Total Debt

    $5.53M
    PLX annual total debt is $5.53 million

    Total Debt 1-Year Change

    -78.97%
    PLX annual total debt is down -78.97% year-on-year

    Long Term Debt

    $4.03M
    PLX annual long term debt is $4.03 million

    Short Term Debt

    $1.50M
    PLX annual short term debt is $1.50 million

    Equity & Capital

    Shareholders Equity

    $43.21M
    PLX annual stockholders equity is $43.21 million

    Book Value

    $43.21M
    PLX annual book value is $43.21 million

    Retained Earnings

    -$378.39M
    PLX annual retained earnings is -$378.39 million

    Working Capital

    $34.46M
    PLX annual working capital is $34.46 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $8.67M
    PLX annual cash from operations is $8.67 million

    Cash From Operations 1-Year Change

    +758.12%
    PLX annual cash from operations is up +758.12% year-on-year

    Cash From Investing

    $4.22M
    PLX annual cash from investing is $4.22 million

    Cash From Investing 1-Year Change

    +125.26%
    PLX annual cash from investing is up +125.26% year-on-year

    Cash From Financing

    -$16.79M
    PLX annual cash from financing is -$16.79 million

    Cash From Financing 1-Year Change

    -168.09%
    PLX annual cash from financing is down -168.09% year-on-year

    CAPEX

    CAPEX

    $1.28M
    PLX annual capital expenditures is $1.28 million

    CAPEX 1-Year Change

    +11.58%
    PLX annual capital expenditures is up +11.58% year-on-year

    Free Cash Flow

    Free Cash Flow

    $7.39M
    PLX annual free cash flow is $7.39 million

    Free Cash Flow 1-Year Change

    +399.64%
    PLX annual free cash flow is up +399.64% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    54.46%
    PLX annual gross profit margin is 54.46%

    Operating Margin

    7.34%
    PLX annual operating profit margin is 7.34%

    Net Margin

    5.49%
    PLX annual net profit margin is 5.49%

    ROA & ROE

    ROA

    3.71%
    PLX annual return on assets is 3.71%

    ROE

    7.64%
    PLX annual return on equity is 7.64%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    28.92
    PLX price to earnings ratio is 28.92

    PE Ratio Sector Percentile

    53.95%
    PLX price to earnings ratio is higher than 53.95% of companies in Healthcare sector

    PB Ratio

    PB Ratio

    3.42
    PLX price to book ratio is 3.42

    PB Ratio Sector Percentile

    66.53%
    PLX price to book ratio is higher than 66.53% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    2.75
    PLX price to sales ratio is 2.75

    PS Ratio Sector Percentile

    43.4%
    PLX price to sales ratio is higher than 43.4% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $142.58M
    PLX enterprise value is $142.58 million

    Enterprise Value Sector Percentile

    49.11%
    PLX enterprise value is higher than 49.11% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    14.86
    PLX EV/EBITDA is 14.86

    EV/EBITDA Sector Percentile

    86.73%
    PLX EV/EBITDA is higher than 86.73% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.34
    PLX annual current ratio is 2.34

    Quick Ratio

    1.52
    PLX annual quick ratio is 1.52

    Leverage

    Debt To Equity

    0.13
    PLX annual debt to equity ratio is 0.13

    Interest Coverage Ratio

    -
    PLX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    6
    PLX piotroski f-score is 6

    Altman Z-Score

    -2.30
    PLX altman z-score is -2.30

    Analyst ratings

    Recent major analysts updates

    Feb 3, 25 HC Wainwright & Co.
    Buy
    Nov 14, 23 HC Wainwright & Co.
    Buy
    Oct 31, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with PLX included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Most recommended stocks
    Best performing stocks last 3 months
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    • What is the ticker symbol for Protalix BioTherapeutics, Inc.?
    • Does Protalix BioTherapeutics, Inc. pay dividends?
    • What sector is Protalix BioTherapeutics, Inc. in?
    • What industry is Protalix BioTherapeutics, Inc. in?
    • What country is Protalix BioTherapeutics, Inc. based in?
    • When did Protalix BioTherapeutics, Inc. go public?
    • Is Protalix BioTherapeutics, Inc. in the S&P 500?
    • Is Protalix BioTherapeutics, Inc. in the NASDAQ 100?
    • Is Protalix BioTherapeutics, Inc. in the Dow Jones?
    • When was Protalix BioTherapeutics, Inc.'s last earnings report?
    • When does Protalix BioTherapeutics, Inc. report earnings?

    What is the ticker symbol for Protalix BioTherapeutics, Inc.?

    The ticker symbol for Protalix BioTherapeutics, Inc. is NYSEAmerican:PLX

    Does Protalix BioTherapeutics, Inc. pay dividends?

    No, Protalix BioTherapeutics, Inc. does not pay dividends

    What sector is Protalix BioTherapeutics, Inc. in?

    Protalix BioTherapeutics, Inc. is in the Healthcare sector

    What industry is Protalix BioTherapeutics, Inc. in?

    Protalix BioTherapeutics, Inc. is in the Biotechnology industry

    What country is Protalix BioTherapeutics, Inc. based in?

    Protalix BioTherapeutics, Inc. is headquartered in United States

    When did Protalix BioTherapeutics, Inc. go public?

    Protalix BioTherapeutics, Inc.'s initial public offering (IPO) was on May 15, 1998

    Is Protalix BioTherapeutics, Inc. in the S&P 500?

    No, Protalix BioTherapeutics, Inc. is not included in the S&P 500 index

    Is Protalix BioTherapeutics, Inc. in the NASDAQ 100?

    No, Protalix BioTherapeutics, Inc. is not included in the NASDAQ 100 index

    Is Protalix BioTherapeutics, Inc. in the Dow Jones?

    No, Protalix BioTherapeutics, Inc. is not included in the Dow Jones index

    When was Protalix BioTherapeutics, Inc.'s last earnings report?

    Protalix BioTherapeutics, Inc.'s most recent earnings report was on August 14, 2025

    When does Protalix BioTherapeutics, Inc. report earnings?

    The next expected earnings date for Protalix BioTherapeutics, Inc. is November 13, 2025
    On this page